Wed, Aug 21, 2024
Indoco Remedies Ltd has received final approval from the USFDA to market its generic Lofexidine tablets, used in opioid discontinuation treatment. The approval grants Indoco 180 days of Competitive Generic Therapy (CGT) exclusivity.
More >
Thu, Jun 06, 2024
Indoco Remedies on Thursday said it has received approval from the US health regulator to market a generic diabetes medication.
Mon, Jun 05, 2023
Indoco Remedies share price: The USFDA had inspected its sterile facility (Plant II), located at Goa ("Facility"), from February 20, 2023, to February 28, 2023, and the said facility had four observations in Form 483.
Wed, May 18, 2022
Expecting more growth in margins going forward, US business is seeing good growth: Aditi Kare Panandikar, MD, Indoco Remedies
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
